We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals SRSF9 promotes RNA alternative splicing in ovarian cancer, indicating m6A modification inhibition.
Prediction of SRSF9 phase separation potential by using public tools.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: